Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.
Saved in:
| Title: | Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. |
|---|---|
| Authors: | Delahunt B; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: brett.delahunt@otago.ac.nz., Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Atkinson C; St Georges Cancer Care Centre, Christchurch, New Zealand., Christie D; Genesis Care, Tugun, Qld, Australia., Duchesne G; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia., Egevad L; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden., Joseph D; Sir Charles Gairdner Hospital, Perth, WA, Australia., Kenwright DN; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Matthews J; Auckland City Hospital, Auckland, New Zealand., Murray JD; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Oldmeadow C; Hunter Medical Research Institute, Newcastle, NSW, Australia., Samaratunga H; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia., Spry NA; Genesis Care, Perth, WA, Australia., Thunders MC; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand., Hondermarck H; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia., Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia. |
| Source: | Pathology [Pathology] 2022 Feb; Vol. 54 (1), pp. 49-54. Date of Electronic Publication: 2021 Dec 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3931 (Electronic) Linking ISSN: 00313025 NLM ISO Abbreviation: Pathology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34955242 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Delahunt+B%22">Delahunt B</searchLink>; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand. Electronic address: brett.delahunt@otago.ac.nz.<br /><searchLink fieldCode="AU" term="%22Steigler+A%22">Steigler A</searchLink>; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Atkinson+C%22">Atkinson C</searchLink>; St Georges Cancer Care Centre, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Christie+D%22">Christie D</searchLink>; Genesis Care, Tugun, Qld, Australia.<br /><searchLink fieldCode="AU" term="%22Duchesne+G%22">Duchesne G</searchLink>; Peter MacCallum Cancer Centre and University of Melbourne, Vic, Australia.<br /><searchLink fieldCode="AU" term="%22Egevad+L%22">Egevad L</searchLink>; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Joseph+D%22">Joseph D</searchLink>; Sir Charles Gairdner Hospital, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Kenwright+DN%22">Kenwright DN</searchLink>; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Matthews+J%22">Matthews J</searchLink>; Auckland City Hospital, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Murray+JD%22">Murray JD</searchLink>; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Oldmeadow+C%22">Oldmeadow C</searchLink>; Hunter Medical Research Institute, Newcastle, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Samaratunga+H%22">Samaratunga H</searchLink>; Aquesta Uropathology and University of Queensland, Brisbane, Qld, Australia.<br /><searchLink fieldCode="AU" term="%22Spry+NA%22">Spry NA</searchLink>; Genesis Care, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Thunders+MC%22">Thunders MC</searchLink>; Department of Pathology and Molecular Medicine and Health Sciences, University of Otago, and Southern Community Laboratory, Wellington, New Zealand.<br /><searchLink fieldCode="AU" term="%22Hondermarck+H%22">Hondermarck H</searchLink>; Hunter Medical Research Institute, Newcastle, NSW, Australia; School of Biomedical Sciences and Pharmacy, University of Newcastle, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Denham+JW%22">Denham JW</searchLink>; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220175411%22">Pathology</searchLink> [Pathology] 2022 Feb; Vol. 54 (1), pp. 49-54. <i>Date of Electronic Publication: </i>2021 Dec 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0175411 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-3931 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200313025%22">00313025 </searchLink><i>NLM ISO Abbreviation: </i>Pathology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34955242 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.pathol.2021.11.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 49 Titles: – TitleFull: Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Delahunt B – PersonEntity: Name: NameFull: Steigler A – PersonEntity: Name: NameFull: Atkinson C – PersonEntity: Name: NameFull: Christie D – PersonEntity: Name: NameFull: Duchesne G – PersonEntity: Name: NameFull: Egevad L – PersonEntity: Name: NameFull: Joseph D – PersonEntity: Name: NameFull: Kenwright DN – PersonEntity: Name: NameFull: Matthews J – PersonEntity: Name: NameFull: Murray JD – PersonEntity: Name: NameFull: Oldmeadow C – PersonEntity: Name: NameFull: Samaratunga H – PersonEntity: Name: NameFull: Spry NA – PersonEntity: Name: NameFull: Thunders MC – PersonEntity: Name: NameFull: Hondermarck H – PersonEntity: Name: NameFull: Denham JW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2022 Feb Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1465-3931 Numbering: – Type: volume Value: 54 – Type: issue Value: 1 Titles: – TitleFull: Pathology Type: main |
| ResultId | 1 |
